| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1080/08916930701694717 |
| P698 | PubMed publication ID | 18365836 |
| P50 | author | Georg Schett | Q73565915 |
| P2860 | cites work | Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation | Q24311588 |
| Osteoprotegerin: a novel secreted protein involved in the regulation of bone density | Q24313918 | ||
| RANK is essential for osteoclast and lymph node development | Q24598872 | ||
| Bone resorption by osteoclasts | Q28145169 | ||
| Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis | Q28202653 | ||
| Denosumab in postmenopausal women with low bone mineral density | Q28298728 | ||
| Cytokines in the pathogenesis of rheumatoid arthritis | Q28303865 | ||
| Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group | Q29616063 | ||
| Evolving concepts of rheumatoid arthritis | Q29618020 | ||
| Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand | Q29619331 | ||
| Measuring function in rheumatoid arthritis: Identifying reversible and irreversible components | Q33256077 | ||
| The links between joint damage and disability in rheumatoid arthritis | Q33867923 | ||
| Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-cont | Q34547981 | ||
| Osteoclasts are essential for TNF-alpha-mediated joint destruction | Q34826003 | ||
| Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis | Q34967810 | ||
| TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis | Q35788463 | ||
| Understanding the genetic contribution to rheumatoid arthritis | Q36101629 | ||
| Interleukin-18 (interferon-gamma-inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony-stimulating factor and not via interferon-gamma to inhibit osteoclast formation | Q36377004 | ||
| Smoking as a trigger for inflammatory rheumatic diseases | Q36672505 | ||
| TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand | Q37413745 | ||
| Rheumatoid arthritis: disappointing long-term outcomes despite successful short-term clinical trials | Q39549617 | ||
| Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction | Q41927546 | ||
| The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis | Q42661052 | ||
| Tumor necrosis factor alpha-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin | Q43937881 | ||
| Analysis of the kinetics of osteoclastogenesis in arthritic rats | Q46513897 | ||
| RANK signaling is not required for TNFalpha-mediated increase in CD11(hi) osteoclast precursors but is essential for mature osteoclast formation in TNFalpha-mediated inflammatory arthritis. | Q51032592 | ||
| The validity and predictive value of magnetic resonance imaging erosions in rheumatoid arthritis: Comment on the article by Goldbach-Mansky et al | Q56420610 | ||
| Interleukin-6 modulates production of T lymphocyte–derived cytokines in antigen-induced arthritis and drives inflammation-induced osteoclastogenesis | Q57265520 | ||
| T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ | Q59064307 | ||
| The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene | Q59092154 | ||
| P433 | issue | 3 | |
| P921 | main subject | inflammation | Q101991 |
| P304 | page(s) | 224-229 | |
| P577 | publication date | 2008-04-01 | |
| P1433 | published in | Autoimmunity | Q4826348 |
| P1476 | title | Review: Immune cells and mediators of inflammatory arthritis | |
| P478 | volume | 41 |
| Q34410537 | 1,25-Dihydroxyvitamin D3 prevents bone loss of the secondary spongiosa in arthritic rats by an increase of bone formation and mineralization and inhibition of bone resorption |
| Q42293325 | A Pronounced Inflammatory Activity Characterizes the Early Fracture Healing Phase in Immunologically Restricted Patients |
| Q51771118 | A significantly impaired natural killer cell activity due to a low activity on a per-cell basis in rheumatoid arthritis. |
| Q34027510 | Accelerated hand bone mineral density loss is associated with progressive joint damage in hands and feet in recent-onset rheumatoid arthritis |
| Q42941036 | Acid-Sensing Ion Channels as Potential Therapeutic Targets in Neurodegeneration and Neuroinflammation. |
| Q21093257 | Advances in rheumatology: new targeted therapeutics |
| Q43671171 | Association between ankylosing spondylitis and chronic periodontitis: a population-based study |
| Q41993031 | Binding immunoglobulin protein resolves rheumatoid synovitis: a xenogeneic study using rheumatoid arthritis synovial membrane transplants in SCID mice |
| Q38598776 | Can rheumatoid arthritis ever cease to exist: a review of various therapeutic modalities to maintain drug-free remission? |
| Q39998140 | Changes in hand bone mineral density and the association with the level of disease activity in patients with rheumatoid arthritis: bone mineral density measurements in a multicenter randomized clinical trial |
| Q35096891 | Clinical predictors of erosion-free status in rheumatoid arthritis: a prospective cohort study |
| Q36838568 | Dendritic cell-mediated in vivo bone resorption. |
| Q37428563 | Different expression levels of TNF receptors on the rheumatoid synovial macrophages derived from surgery and a synovectomy as detected by a new flow cytometric analysis |
| Q37411976 | Disease Activity and Bone Mineral Density of MCP Joints in Patients with Rheumatoid and Psoriatic Arthritis: Is There a Correlation?-A Study in Patients Treated with Methotrexate and an Anti-TNF α Agent |
| Q38537751 | Drug Trafficking into Macrophages via the Endocytotic Receptor CD163. |
| Q41883420 | Effect of Tumor Necrosis Factor Inhibitor Therapy on Osteoclasts Precursors in Rheumatoid Arthritis |
| Q91860943 | Effects of the IL-23-IL-17 pathway on bone in spondyloarthritis |
| Q54655741 | Elevated cytokine production restores bone resorption by human Btk-deficient osteoclasts. |
| Q36213688 | Generation and characterization of ABT-981, a dual variable domain immunoglobulin (DVD-Ig(TM)) molecule that specifically and potently neutralizes both IL-1α and IL-1β. |
| Q52723047 | Histological Evaluation of Lumbar Spine Changes in Rats with Collagen-induced Arthritis. |
| Q42956804 | IL-6 increases B-cell IgG production in a feed-forward proinflammatory mechanism to skew hematopoiesis and elevate myeloid production |
| Q38114066 | Immunological reaction in TNF-α-mediated osteoclast formation and bone resorption in vitro and in vivo |
| Q34683465 | Inflammation, but not hypoxia, mediated HIF-1alpha activation depends on COX-2 |
| Q59138385 | Inhibitory Effect of Methotrexate on Rheumatoid Arthritis Inflammation and Comprehensive Metabolomics Analysis Using Ultra-Performance Liquid Chromatography-Quadrupole Time of Flight-Mass Spectrometry (UPLC-Q/TOF-MS) |
| Q36151103 | Insulin-Like Growth Factor I Does Not Drive New Bone Formation in Experimental Arthritis |
| Q36084929 | Interleukin-34 produced by human fibroblast-like synovial cells in rheumatoid arthritis supports osteoclastogenesis |
| Q50218797 | Lemnalol attenuates mast cell activation and osteoclast activity in a gouty arthritis model. |
| Q38916588 | Margaritaria discoidea (Euphorbiaceae) stem bark extract attenuates allergy and Freund's adjuvant-induced arthritis in rodents |
| Q39154222 | Mean platelet volume as a marker for differentiating disease flare from infection in Behçet's disease |
| Q38121969 | Molecular hydrogen: new antioxidant and anti-inflammatory therapy for rheumatoid arthritis and related diseases |
| Q42291940 | Overexpression of heparanase enhances T lymphocyte activities and intensifies the inflammatory response in a model of murine rheumatoid arthritis |
| Q39642662 | Pasteurella multocidaToxin-Stimulated Osteoclast Differentiation Is B Cell Dependent |
| Q38154934 | Preliminary analysis of mortality associated with rituximab use in autoimmune diseases |
| Q46063213 | Proceedings of the 2017 National Toxicology Program Satellite Symposium |
| Q40286666 | Protective role of systemic furin in immune response-induced arthritis. |
| Q35834435 | Reactivity of rat bone marrow-derived macrophages to neurotransmitter stimulation in the context of collagen II-induced arthritis |
| Q37358099 | Recent advances in neutralizing the IL-6 pathway in arthritis. |
| Q46121871 | Serum IFN-λ1 is abnormally elevated in rheumatoid arthritis patients |
| Q48359135 | Study of the inhibitory effects on TNF-α-induced NF-κB activation of IMD0354 analogs. |
| Q35655587 | Suppression of Peripheral Pain by Blockade of Voltage-Gated Calcium 2.2 Channels in Nociceptors Induces RANKL and Impairs Recovery From Inflammatory Arthritis in a Mouse Model. |
| Q41859433 | Synergistic induction of local glucocorticoid generation by inflammatory cytokines and glucocorticoids: implications for inflammation associated bone loss. |
| Q29048648 | Systemic IL-6 Effector Response in Mediating Systemic Bone Loss Following Inhalation of Organic Dust |
| Q38071672 | Targeted drug delivery to macrophages |
| Q39778097 | Targeting extracellular signal-regulated kinase (ERK) signaling has therapeutic implications for inflammatory osteolysis |
| Q37699343 | The interferon-inducible HIN-200 gene family in apoptosis and inflammation: implication for autoimmunity |
| Q38179461 | Therapeutic targets for rheumatoid arthritis: Progress and promises |
| Q28385635 | Toll-Like Receptor 4 Signaling Pathway Mediates Inhalant Organic Dust-Induced Bone Loss |
| Q37402405 | Transforming growth factor beta is dispensable for the molecular orchestration of Th17 cell differentiation |
| Q35146135 | Vascular endothelial growth factor C attenuates joint damage in chronic inflammatory arthritis by accelerating local lymphatic drainage in mice |
| Q28393736 | Vitamin D supplementation protects against bone loss following inhalant organic dust and lipopolysaccharide exposures in mice |
Search more.